What happened
Original notice title
Richardson Nutritional Center, LLC/Nutriseeds, Inc. MARCS-CMS 610544, February 19, 2021
From the archived source record
Examples of some of the claims that provide evidence that your products are intended for use as drugs include the following: Regarding your Nutriseeds Fresh Bitter Apricot Seeds and Nutriseeds Natural Amygdalin Extract products: On your website www.californiaapricotseeds.com: • “Studies have shown that B17 may help boost immunity by slowing down the spread of illness throughout the body by killing harmful cells ….” This website also contains evidence of intended use in the form of personal testimonials recommending or describing the use of your products for the cure, mitigation, treatment, or prevention of disease. A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your Nutriseeds Fresh Bitter Apricot Seeds, Nutriseeds Natural Amygdalin Extract, Nutriseeds Natural B15 – Pangamic Acid, RNC Bitter Raw Apricot Seeds, and RNC Laetrile B17 products fail to bear adequate directions for their intended uses and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. § 331(a)]. The violations cited in this letter are not intended to be an all-inclusive statement of violations that exist in connection with your products. You are responsible for investigating and determining the causes of any violations and for preventing their recurrence or the occurrence of other violations. You should take prompt action to address the violations cited in this letter. Failure to address these violations may result in legal action without further notice, including, without limitation, seizure and injunction.
What the official notice says to do
Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice →Status and source details
- Status recorded in the archive
- No closeout listed in FDA table
- Source checked
- Jul 16, 2026
- Record revision
- fef1aef4f0c0
This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage →